EDN1 and renal fibrosis: It significantly reduced cardiac and renal fibrosis and suppressed the expression of pro-inflammatory (IL-1β, TNF-α), pro-fibrotic (Col1A1, α-SMA), and cardiac stress (BNP, ET-1, ANF) markers (Figure 3 and Figure 4).